KPC Pharmaceuticals, Inc.SSE: 600422

Report for Q1 2026

Apr 25, 2026 · Issued by KPC Pharmaceuticals, Inc. via Shanghai Stock Exchange

Filed with SSE · Apr 25, 2026

On 6ix: 6ix.com/news/report-for-q1-2026-133

Report for Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

KPC Pharmaceuticals, Inc. on 6ix

Earlier from KPC Pharmaceuticals

Announcement on Obtaining Drug Registration CertificateApr 21
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026Apr 18
Announcement on Change of Senior Management MemberApr 1
Indicative Announcement on the Publication of the 2025 Performance Announcement by CR Pharmaceutical Group Co., Ltd., an Indirectly Controlling Shareholder of the Controlling ShareholderMar 26
Notice on Convening the 1st Extraordinary General Meeting in 2026Mar 24

Later from KPC Pharmaceuticals

All KPC Pharmaceuticals news releases

Follow KPC Pharmaceuticals into a list and get an email when it puts out news.

Follow KPC Pharmaceuticals